AMY-109

N/A

Report date: 2024/02/26 13:07:33

Base Information

Drug NameAMY-109
Drug Alias NameAMY-109AMY109
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Interleukin-8
TargetsInterleukin-8
Therapy Area/IndicationsSolid tumoursEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A